CHINWAGYThe world's live brand collaboration wire
Join freeCreatorsIndustryContact
For you +
ReadersCreatorsBrands & IndustryContact Chinwagy

THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196

Regeneron×Tessera Therapeutics
Official image for Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196
Official collaboration image · verified from the named source

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Regeneron and Tessera agreed to jointly develop and commercialize TSRA-196 for alpha-1 antitrypsin deficiency, sharing worldwide development costs and future profits.

Current status
Official collaboration
Known availability
The official source confirms the collaboration; timing details remain under review.
Place
Tarrytown, United States
Source checked
September 16, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.